TY - JOUR
T1 - The Role of Sex-Specific Risk Factors in the Risk Assessment of Atherosclerotic Cardiovascular Disease for Primary Prevention in Women
AU - Freaney, Priya M.
AU - Khan, Sadiya S.
AU - Lloyd-Jones, Donald M.
AU - Stone, Neil J.
N1 - Funding Information:
This research was supported by grants from the National Institutes of Health/National Heart, Lung, and Blood Institute (KL2TR001424), and the American Heart Association (AHA#19TPA34890060) to Dr. Khan. Research reported in this publication was supported, in part, by the National Institutes of Health’s National Center for Advancing Translational Sciences, Grant Number KL2TR001424 (SSK). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Purpose of Review: Robust evidence is emerging regarding the contribution of sex-specific risk factors to a woman’s unique risk of atherosclerotic cardiovascular disease (ASCVD). This review summarizes the available literature regarding the association of sex-specific risk factors and ASCVD in women. Recent Findings: The American College of Cardiology and American Heart Association Guidelines recommend estimation of 10-year risk of a first ASCVD event using the 2013 Pooled Cohort Equations. This can be further personalized by identifying sex-specific risk factors present in a woman’s history. There are multiple vulnerable periods across a woman’s life course that are associated with increased risk of ASCVD. Risk factors across the reproductive life course that have been shown to correlate with higher risk for future ASCVD include early menarche, adverse pregnancy outcomes (such as pre-eclampsia or preterm birth), and early natural or surgical menopause. In addition, certain conditions that are more common among women, including autoimmune diseases, history of chest irradiation, and certain chemotherapies, also need to be considered. Finally, risk assessment can be refined with subclinical disease imaging (coronary calcium score) if there remains uncertainty about clinical management with lipid-lowering therapies for primary prevention after inclusion of these risk enhancers. Summary: Risk assessment for ASCVD in women requires a personalized approach that incorporates sex-specific risk factors to guide primary prevention measures, such as lipid-lowering therapies. Coronary calcium score imaging may also help further refine risk assessment, but no clinical trials conducted to date have addressed this question.
AB - Purpose of Review: Robust evidence is emerging regarding the contribution of sex-specific risk factors to a woman’s unique risk of atherosclerotic cardiovascular disease (ASCVD). This review summarizes the available literature regarding the association of sex-specific risk factors and ASCVD in women. Recent Findings: The American College of Cardiology and American Heart Association Guidelines recommend estimation of 10-year risk of a first ASCVD event using the 2013 Pooled Cohort Equations. This can be further personalized by identifying sex-specific risk factors present in a woman’s history. There are multiple vulnerable periods across a woman’s life course that are associated with increased risk of ASCVD. Risk factors across the reproductive life course that have been shown to correlate with higher risk for future ASCVD include early menarche, adverse pregnancy outcomes (such as pre-eclampsia or preterm birth), and early natural or surgical menopause. In addition, certain conditions that are more common among women, including autoimmune diseases, history of chest irradiation, and certain chemotherapies, also need to be considered. Finally, risk assessment can be refined with subclinical disease imaging (coronary calcium score) if there remains uncertainty about clinical management with lipid-lowering therapies for primary prevention after inclusion of these risk enhancers. Summary: Risk assessment for ASCVD in women requires a personalized approach that incorporates sex-specific risk factors to guide primary prevention measures, such as lipid-lowering therapies. Coronary calcium score imaging may also help further refine risk assessment, but no clinical trials conducted to date have addressed this question.
KW - Adverse pregnancy outcomes
KW - Atherosclerotic cardiovascular disease
KW - Primary prevention
KW - Risk prediction
KW - Sex-specific risk factors
UR - http://www.scopus.com/inward/record.url?scp=85088158305&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088158305&partnerID=8YFLogxK
U2 - 10.1007/s11883-020-00864-6
DO - 10.1007/s11883-020-00864-6
M3 - Review article
C2 - 32671475
AN - SCOPUS:85088158305
VL - 22
JO - Current Atherosclerosis Reports
JF - Current Atherosclerosis Reports
SN - 1523-3804
IS - 9
M1 - 46
ER -